The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...
Nektar announces clinical trial agreement to evaluate rezpegaldesleukin in patients with new onset type 1 diabetes mellitus: San Francisco Tuesday, February 25, 2025, 18:00 Hrs [I ...
Eli Lilly and Company announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program.1 Lilly also reduced the ...
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, is hosting an R&D Day today in New York City and will also webcast the event. The Company plans to showcase its R&D progress and ...